All In MedTech

FDA Clearance Tracker · P140031-S015

SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 19, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 19, 2016

Approved

Time to decision

119 days

Received Apr 22, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P140031-S015
Device name
SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES
Applicant location
Irvine, CA
Received
Apr 22, 2016
Decided
Aug 19, 2016
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P140031

Device type

Device class
Class III

Every decision under product code NPT

FDA's approval statement

As written in FDA's record.

Approval for various changes to the post-approval study protocol for the continued follow-up of the IDE High Risk Patients Cohort.

Source documents

Other decisions for Edwards Lifesciences, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.